Modernizing Peptide Manufacturing Capabilities for Individualized Cancer Vaccines

• Promising clinical results has opened the door to exploiting the benefits of individualized cancer vaccines
• Peptides as a vaccine modality brings many benefits as described by real examples
• Standardized manufacturing brings benefits in reduced manufacturing time and costs

Speakers:

Alastair Hay

Vice President Peptides

Almac